PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Mirroring the obesity pandemic, nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease affecting populations worldwide. Approximately 30% of the adult United States (US) population is estimated to be afflicted with NAFLD. NAFLD is a spectrum of liver disease ranging from nonalcoholic fatty liver (NAFL), the non-progressive sub-type, to nonalcoholic steatohepatitis (NASH), the progressive sub-type, which can lead to progressive liver disease leading to cirrhosis and hepatocellular carcinoma(1).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · cited 1×
“NAFLD is a spectrum of liver disease ranging from nonalcoholic fatty liver (NAFL), the nonprogressive subtype, to nonalcoholic steatohepatitis (NASH), the progressive subtype, which can lead to progressive liver disease, leading to cirrhosis and hepatocellular carcinoma (HCC).(1) NAFLD is considered the hepatic manife…”
BackgroundSelf-citationLiu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A.-C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.030 · Cited by 549 · cited 2×
“In previous studies, MM homozygotes had an approximately 2-fold higher risk of steatosis,(5) a 3-fold to 4-fold higher risk of NASH(6) and cirrhosis,(7) and an up to 12-fold higher risk of HCC,(8) as compared with II homozygotes.”
BackgroundResultA meta-analysis of genome-wide association studies identifies multiple longevity genes
Deelen, J., Evans, D. S., Arking, D. E., Tesi, N., Nygaard, M., Liu, X., Wojczynski, M. K., Biggs, M. L., van der Spek, A., Atzmon, G., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11558-2 · Cited by 370
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
“Risks associated with the I148M PNPLA3 SNP have been replicated in multiple independent cohorts (Stender and Loomba, 2020).”
BackgroundSelf-citationGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Self-citationMetabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W. S., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki-Järvinen, H., & Loomba, R. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 293
Self-citationCarlsson, B., Lindén, D., Brolén, G., Liljeblad, M., Bjursell, M., Romeo, S., & Loomba, R. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15738 · Cited by 169
Self-citationPaolini, E., Longo, M., Meroni, M., Tria, G., Cespiati, A., Lombardi, R., Badiali, S., Maggioni, M., Fracanzani, A. L., & Dongiovanni, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1101341 · Cited by 11
“Moreover, the homozygosity for PNPLA3 risk allele has been associated with more than 2-fold greater risk to develop NASH and cirrhosis, with up to a 12-fold increased risk for HCC and with an 18-fold increase in liverrelated mortality (5, 6), thus suggesting a dose-dependent allele risk.”
Background
Metadata
- Authors
- Stender, S., & Loomba, R.
- Venue
- Hepatology
- Published
- 2020-03
- Volume
- 71
- Issue
- 3
- Pages
- 777-779
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2999277101
- Cited by
- 43
- References
- 3
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality. https://app.cochat.ai/papers/10.1002/hep.31113
- The paper
- Stender, S., & Loomba, R. (2020). PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality. Hepatology. https://doi.org/10.1002/hep.31113
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.